Advancing Immunology Clinical Development
Immunology studies can involve very different patient populations, therapeutic approaches, and regulatory requirements depending on the indication. Programs may also span biologics, biosimilars, antibodies, biomarker-driven development, precision medicine, and emerging immunotherapies.
Regulatory and Development Support
- Global regulatory expertise for strategy and submissions
- Support from early development through approval
- Integrated operational and regulatory support across major global markets
Support for Complex Immunology Programs
- Flexible delivery to meet program needs
- Support across diverse immunology indications
- Biologics, biosimilars, monoclonal and bispecific antibodies, and emerging immunotherapies
- Biomarker-driven development, precision medicine, and complex endpoint strategies
Global Clinical Development Experience
- Access to experienced immunology investigators, specialist sites, and patient populations
- From first-in-human studies through registration-enabling programs
- Regional expertise in key immunology research markets
Early Development
Through ApprovalGlobal Regulatory &
Operational SupportTherapies Reaching
PatientsQuality & Compliance
at Every StepScientific Excellence
& InnovationData Integrity &
Transparency
Immunology Experience at a Glance
519
Immunology studies conducted
1259
Immunology investigators and key opinion leaders engaged
1364
Immunology sites activated globally
41
Countries supporting Immunology programs
5875
Immunology patients enrolled
84
Immunology indications supported
Breadth of Immunology Experience
Our experience spans a broad range of immunology indications, study designs, therapeutic approaches, and research settings.
Indication Experience
- Experience across autoimmune, inflammatory, dermatologic, rheumatologic, and rare immune-mediated diseases
Study and Therapeutic Experience
- Experience supporting complex study designs, biomarker-driven programs, and precision medicine approaches
- Experience across small molecules, antibodies, immunotherapies, RNA, cell and gene therapies
Research Networks and Market Access
- Established relationships with investigators, specialist treatment centers, and clinical research networks
- Access to diverse patient populations across established and emerging research markets
Immunology Indications
Hover over each indication to explore conditions studied
Blood Diseases Alloimmune Thrombocytopenia; Autoimmune Haemolytic Anaemia, Cold Type; Autoimmune Haemolytic Anaemia, Warm Type; Immune Thrombocytopenic Purpura; Thrombotic Microangiopathy
Skin Diseases Alopecia; Alopecia Areata; Atopic Eczema; Dermatitis and Eczema; Generalised Pustular Psoriasis; Hidradenitis Suppurativa; Idiopathic angioedema; Palmoplantar Pustulosis; Pemphigus; Pemphigus foliaceus; Pemphigus Vulgaris; Plaque Psoriasis; Psoriasis; Pyoderma Gangrenosum; Vitiligo
Respiratory System Allergic Asthma; Allergic Rhinitis; Allergic Rhinitis due to House Dust Mite; Asthma; Chronic Rhinosinusitis; Vasomotor or Allergic Rhinitis
Visual System Optic Neuritis
Musculoskeletal System Axial Spondyloarthritis; Inflammatory Inclusion Body Myositis; Osteomyelitis or Osteitis; Psoriatic arthritis; Rheumatoid arthritis
Injury Failure or Rejection of Transplanted Organ
Digestive System Coeliac Disease; Crohn Disease; Inflammatory Bowel Diseases; Primary Biliary Cholangitis; Primary Sclerosing Cholangitis; Ulcerative Colitis
Genitourinary System Glomerular Diseases
Health Status Factor Transplanted Kidney; Transplanted Lung; Transplanted Stem Cell
Immune System Acquired Angioedema; Allergy; Anaphylaxis; Autoinflammatory Disorders; Defects in the Complement System; Dermatomyositis; Graft-Versus-Host Disease; Hereditary Angioedema; Idiopathic Inflammatory Myopathy; Immune System Disorders; Immunodeficiencies with Antibody Defects; Lupus Erythematosus; Severe Combined Immunodeficiencies; Sjogren Syndrome; Systemic Autoimmune Disorders; Systemic Lupus Erythematosus; Systemic Sclerosis; Vasculitis
Nervous System Chronic Inflammatory Demyelinating Polyneuropathy; Congenital Myasthenia Syndrome; Guillain Barre Syndrome; Multiple Sclerosis; Myasthenia Gravis; Neuromyelitis Optica Spectrum
Therapeutic Approaches in Immunology
Biologics & Antibody-Based Therapies
- Monoclonal Antibodies
- Bispecific Antibodies
- Cytokine-Targeted Therapies
- Biosimilars
Precision & Targeted Immunology
- Biomarker-Driven Therapies
- Precision Medicine Approaches
- Targeted Immune Modulation
- Personalized Treatment Strategies
Advanced Therapeutic Approaches
- Cell Therapies
- Gene Therapies
- RNA-Based Therapeutics
- Next-Generation Immunotherapies
Expertise That Guides Infectious Disease Development
Our infectious disease leadership brings extensive therapeutic, clinical, and operational experience to help sponsors make informed development decisions and successfully execute trials across regions.







